4//SEC Filing
Ribeiro Ramiro 4
Accession 0001562180-25-000230
CIK 0001314102other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:04 PM ET
Size
8.1 KB
Accession
0001562180-25-000230
Insider Transaction Report
Form 4
Ribeiro Ramiro
Chief Medical Officer
Transactions
- Award
Restricted Stock Units
2025-01-03+59,000→ 59,000 totalExercise: $0.00→ Common Stock (59,000 underlying) - Award
Stock Option (Right to Buy)
2025-01-03+117,000→ 117,000 totalExercise: $8.26Exp: 2035-01-03→ Common Stock (117,000 underlying)
Footnotes (2)
- [F1]The restricted stock units will vest in three ratable annual installments beginning January 3, 2026.
- [F2]The option to purchase will vest and become exercisable as follows: 25% at January 3, 2026 and the remainder ratably, on a monthly basis, over the remaining three years.
Documents
Issuer
EyePoint Pharmaceuticals, Inc.
CIK 0001314102
Entity typeother
Related Parties
1- filerCIK 0002013623
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 4:04 PM ET
- Size
- 8.1 KB